Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK.
Tappenden P, Navega Biz A, Hernández Alava M, Sasso A, Sutton L, Ennis K, Elliott R, Wildman M. Tappenden P, et al. Among authors: hernandez alava m. Int J Technol Assess Health Care. 2023 Jan 17;39(1):e6. doi: 10.1017/S0266462322003373. Int J Technol Assess Health Care. 2023. PMID: 36647697 Free PMC article.
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P, Devianee Keetharuth A, Brazier J. Longworth L, et al. Among authors: hernandez alava m. Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090. Health Technol Assess. 2014. PMID: 24524660 Free PMC article. Review.
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D, Young A, Wailoo A. Stevenson M, et al. Among authors: hernandez alava m. Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350. Health Technol Assess. 2016. PMID: 27140438 Free PMC article. Review.
Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis.
Thokala P, Hnynn Si PE, Hernandez Alava M, Sasso A, Schaufler T, Soro M, Fotheringham J. Thokala P, et al. Among authors: hernandez alava m. Pharmacoeconomics. 2023 Apr;41(4):457-466. doi: 10.1007/s40273-022-01237-4. Epub 2023 Feb 3. Pharmacoeconomics. 2023. PMID: 36735201 Free PMC article.
Guidance on the use of complex systems models for economic evaluations of public health interventions.
Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O'Flaherty M, Gilbert N, Purshouse R, Robinson S, Dodd PJ, Strong M, Paisley S, Smith R, Briggs A, Shahab L, Occhipinti JA, Lawson K, Bayley T, Smith R, Boyd J, Kadirkamanathan V, Cookson R, Hernandez-Alava M, Jackson CH, Karapici A, Sassi F, Scarborough P, Siebert U, Silverman E, Vale L, Walsh C, Brennan A. Breeze PR, et al. Among authors: hernandez alava m. Health Econ. 2023 Jul;32(7):1603-1625. doi: 10.1002/hec.4681. Epub 2023 Apr 20. Health Econ. 2023. PMID: 37081811 Free PMC article. Review.
46 results